SUZ12 and neoplasm: Both suz12-deficient lines demonstrated a strongly accelerated overall tumor onset and penetrance, in both the p53m/m, nf1b−/−, nf1a+/+ and the p53m/m, nf1b−/−, nf1a+/− backgrounds.